Browsing Pharmacy Faculty Research, Publications and Presentations by Issue Date

Now showing items 21-24 of 24

  • Formation of a Collaborative Interprofessional Primary Healthcare Deprescribing Research Team in Nova Scotia 

    Whelan AM, , Kennie-Kaulbach N, Isenor JE Martin-Misener R, Burge F, Burgess S, Kits O, Reeve E, Salsbury LE, Cormier R, Bai I, MacLean H, Helwig M. Formation of a collaborative interprofessional primary health care deprescribing research team in Nova Scotia. 2019 Association of Faculties of Pharmacy of Canada/Canadian Pharmacy Education and Research Conference. Edmonton, AB, June 12 to 13, 2019; Primary Healthcare Research Day in Halifax NS. June17, 2019. (Presenters: AM Whelan, N Kennie-Kaulbach)
    Study objective: To describe the development of a collaborative interprofessional primary health care deprescribing research team in Nova Scotia. Methods: Initiated by two College of Pharmacy faculty members, a core ...

  • Key Priorities to Implement Deprescribing in Primary Health Care in Nova Scotia: Results from the Deprescribing in Primary Health Care in Nova Scotia Knowledge Exchange Event (June 20, 2019) 

    Isenor JE, Kennie-Kaulbach N, Kehoe S, Bai I, Reeve E, Whelan AM, Burgess S, Kits O, Burge F, Martin-Misener R, Helwig M, Sampalli T (OPTx Team). Key Priorities to Implement Deprescribing in Primary Health Care in Nova Scotia: Results from the Deprescribing in Primary Health Care in Nova Scotia Knowledge Exchange Event (June 20, 2019). Final Report. Halifax (NS). 2020 03 03. 46 p.
    Inappropriate medication use and polypharmacy are associated with increased adverse drug reactions, hospitalizations and mortality. Deprescribing has been found to decrease the use of medications and medication costs and ...

  • Deprescribing Interventions in Primary Health Care Mapped to the Behaviour Change Wheel: A Scoping Review 

    Isenor JE, Bai I, Cormier R, Helwig M, Reeve E, Whelan AM, Burgess S, Martin-Misener R, Kennie-Kaulbach N. Deprescribing Interventions in Primary Health Care Mapped to the Behaviour Change Wheel: A Scoping Review. Res Social Adm Pharm. 2021 Jul;17(7):1229-1241. https://doi.org/10.1016/j.sapharm.2020.09.005
    Background: Polypharmacy and inappropriate medication use are an increasing concern. Deprescribing may improve medication use through planned and supervised dose reduction or stopping of medications. As most medication ...

  • Synthesis of a novel fluorinated phosphonyl C-glycoside, (3-deoxy-3-fluoro- F β-d-glucopyranosyl)methylphosphonate, a potential inhibitor of β- phosphoglucomutase Postprint 

    Published Version: Madison Carroll-Poehls, David L. Jakeman, Synthesis of a novel fluorinated phosphonyl C-glycoside, (3-deoxy-3-fluoro-β-d-glucopyranosyl)methylphosphonate, a potential inhibitor of β-phosphoglucomutase, Carbohydrate Research, 2023, 108979, ISSN 0008-6215, https://doi.org/10.1016/j.carres.2023.108979
    β-phosphoglucomutase (βPGM) catalyzes the conversion of β-glucose 1-phosphate (βG1P) to glucose-6-phosphate (G6P), a universal source of cellular energy, in a two-step process. Transition state analogue (TSA) complexes ...